Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
01 2021
Historique:
received: 24 04 2020
revised: 16 08 2020
accepted: 26 09 2020
pubmed: 16 10 2020
medline: 30 6 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

Congenital glycosylation disorders (CDG) are inherited metabolic diseases due to defective glycoprotein and glycolipid glycan assembly and attachment. MOGS-CDG is a rare disorder with seven patients from five families reported worldwide. We report on a 19-year-old girl with MOGS-CDG. At birth she presented facial dysmorphism, marked hypotonia, and drug-resistant tonic seizures. In the following months, her motility was strongly limited by dystonia, with forced posture of the head and of both hands. She showed a peculiar hyperkinetic movement disorder with a rhythmic and repetitive pattern repeatedly documented on EEG-polygraphy recordings. Brain MRI showed progressive cortical and subcortical atrophy. Epileptic spasms appeared in first months and ceased by the age of 7 years, while tonic seizures were still present at last assessment (19 years). We report the oldest-known MOGS-CDG patient and broaden the neurological phenotype of this CDG.

Identifiants

pubmed: 33058492
doi: 10.1002/ajmg.a.61916
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-222

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

de Praeter, C. M., Gerwig, G. J., Bause, E., Nuytinck, L. K., Vliegenthart, J. F. G., Breuer, W., … van Coster, R. N. (2000). A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. American Journal of Human Genetics, 66, 1744-1756.
Fiumara, A., Barone, R., del Campo, G., Striano, P., & Jaeken, J. (2016). Electroclinical features of early-onset epileptic encephalopathies in congenital disorders of glycosylation (CDGs). JIMD Reports, 27, 93-99.
Jaeken, J., & van den Heuvel, L. (2014). Congenital disorders of glycosilation. In Physician's guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases (pp. 484-511). Berlin, Heidelberg: Springer.
Jaeken, J., Lefeber, D. J., & Matthijs, G. (2020). SRD5A3 defective congenital disorder of glycosylation: Clinical utility gene card. European Journal of Human Genetics, 28, 1297-1300.
Kane, M. S., Davids, M., Adams, C., Wolfe, L. A., Cheung, H. W., Gropman, A., … Boerkoel, C. F. (2016). Mitotic intragenic recombination: A mechanism of survival for several congenital disorders of glycosylation. American Journal of Human Genetics, 98, 339-346.
Kim, Y.-M., Seo, G. H., Jung, E., Jang, J.-H., Kim, S. Z., & Lee, B. H. (2018). Characteristic dysmorphic features in congenital disorders of glycosylation type IIb. Journal of Human Genetics, 63, 383-386.
Li, M., Xu, Y., Wang, Y., Yang, X. A., & Jin, D. (2019). Compound heterozygous variants in MOGS inducing congenital disorders of glycosylation (CDG) IIb. Journal of Human Genetics, 64, 265-268.
Mostile, G., Barone, R., Nicoletti, A., Rizzo, R., Martinelli, D., Sturiale, L., … Zappia, M. (2019). Hyperkinetic movement disorders in congenital disorders of glycosylation. European Journal of Neurology, 26(9), 1226-1234.
Neumann, L. M., von Moers, A., Kunze, J., Blankenstein, O., & Marquardt, T. (2003). Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation. European Journal of Pediatrics, 162, 710-713.
Peiwei Zhao, P. X., Luo, S., Huang, Y., Tan, L., Shao, J., & He, X. (2020). Identification and characterization of novel mutations in MOGS in a Chinese patient with infantile spams. Neurogenetics, 21, 97-104.
Prietsch, V., Peters, V., Hackler, R., Jakobi, R., Assmann, B., Fang, J., … Hoffmann, G. F. (2002). A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. Journal of Inherited Metabolic Disease, 25, 126-130.
Rossi, M., Medina Escobar, A., Ameghino, L., & Merello, M. (2017). Expanding the phenotype of phosphomannomutase-2 gene congenital disorder of glycosylation: Cervical dystonia. Journal of the Neurological Sciences, 378, 52-54.
Sadat, M. A., Moir, S., Chun, T.-W., Lusso, P., Kaplan, G., Wolfe, L., … Rosenzweig, S. D. (2014). Glycosylation, hypogammaglobulinemia, and resistance to viral infections. The New England Journal of Medicine, 370, 1615-1625.

Auteurs

Tommaso Lo Barco (T)

Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Elisa Osanni (E)

Child Neuropsychiatry, Epilepsy and Clinical Neurophysiology Unit, IRCCS "E. Medea", Conegliano, Treviso, Italy.

Andrea Bordugo (A)

Pediatrics Unit, Department of Pediatrics, Regional Center for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Giulia Rodella (G)

Pediatrics Unit, Department of Pediatrics, Regional Center for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Maria Iascone (M)

Laboratorio di Genetica Medica, ASST Papa Giovanni XXIII, Piazza OMS, Bergamo, Italy.

Romano Tenconi (R)

Genetica Clinica, Dipartimento di Pediatria, Università di Padova, Padova, Italy.

Rita Barone (R)

Child Neurology and Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Bernardo Dalla Bernardina (B)

Center for Research on Epilepsies in Pediatric age (CREP), Verona, Italy, Verona, Italy.

Gaetano Cantalupo (G)

Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH